Startups

A-Alpha Bio
Measures, predicts and engineers protein-protein interactions for drug discovery. Its AlphaSeq experimental platform measures large numbers of binding affinities, while AlphaBind machine-learning models predict binding from protein sequences. The company uses these tools for its own therapeutic programs and pharmaceutical partnerships.
Founded 2017
